GlassScriptPhysician profile
Peter J Shoji
NPI 1073570503
$7,856.11
in general payments reported to CMS, 2019-2025
18 companies · $995 in 2025
The $995 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $893 · 2020: $147 · 2021: $1,018 · 2022: $960 · 2023: $2,716 · 2024: $1,127 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,118 · Travel and Lodging: $1,719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,118.35 |
| Travel and Lodging | $1,719.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,709.83 | 2019-2025 | Wavelight Ex500 Excimer Laser |
| Bausch & Lomb Americas INC. | $2,157.04 | 2022-2025 | Infuse, Miebo, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $783.81 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $352.93 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $345.14 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $257.03 | 2021 | |
| Dompe US, INC. | $243.06 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $240.32 | 2019-2022 | |
| New World Medical,INC. | $144.98 | 2019 | |
| Sight Sciences, INC. | $144.34 | 2023 | Omni Surgical System |
| Apellis Pharmaceuticals, INC. | $128.60 | 2025 | Syfovre |
| Oyster Point Pharma, INC. | $123.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $112.47 | 2020 | |
| Allergan, INC. | $34.94 | 2019-2021 | |
| Abbvie INC. | $25.01 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $21.36 | 2025 | Myday Contact Lens |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Shire North American Group INC | $14.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shoji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.